Institute of
bioorganic chemistry

Researchers from the Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Harvard University, Sechenov University, the Pasteur Institute, and other scientific institutions in Russia and abroad have proposed a new method for controlling elevated intraocular pressure, which is a major damaging factor in glaucoma. They have developed a new type of contact lenses that incorporate metal-organic frameworks (MOFs) for the controlled and prolonged release of brimonidine, a medication used to reduce intraocular pressure. This innovation was presented in the high-ranking scientific journal Aggregate, highlighting its innovative nature and potential impact on ophthalmological practice. Learn more